153 related articles for article (PubMed ID: 2652548)
21. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
Chapman JR; Morris PJ
Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
[No Abstract] [Full Text] [Related]
22. Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial.
Lancet; 1983 Oct; 2(8357):986-9. PubMed ID: 6138592
[TBL] [Abstract][Full Text] [Related]
23. Cyclosporine nephrotoxicity and dermal vascular alterations in renal transplants.
Shen SY; Wood C; Amin AN; Papadimitriou JC; Weir MR; Coughlin TR
Transplant Proc; 1989 Feb; 21(1 Pt 2):1508-10. PubMed ID: 2652486
[No Abstract] [Full Text] [Related]
24. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
[No Abstract] [Full Text] [Related]
25. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation.
Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826
[No Abstract] [Full Text] [Related]
26. A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone.
Schweizer RT; Rovelli M; Roper L; Bartus SA
Transplant Proc; 1987 Feb; 19(1 Pt 3):1944-6. PubMed ID: 3079062
[No Abstract] [Full Text] [Related]
27. Quality of life on cyclosporine versus conventional therapy.
Simmons RG; Abress LK
Transplant Proc; 1987 Feb; 19(1 Pt 3):1860-1. PubMed ID: 3079053
[No Abstract] [Full Text] [Related]
28. Cyclosporine (Cy) monotherapy after cadaveric renal transplantation.
Margreiter R; Bösmüller C; Spielberger M; Schmid T; Königsrainer A
Transplant Proc; 1989 Feb; 21(1 Pt 2):1591-3. PubMed ID: 2652518
[No Abstract] [Full Text] [Related]
29. Cyclosporine, combination immunosuppression, and posttransplant diabetes mellitus.
Boudreaux JP; McHugh L; Canafax DM; Asher N; Sutherland DE; Payne W; Simmons RL; Najarian JS; Fryd DS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1811-3. PubMed ID: 3079040
[No Abstract] [Full Text] [Related]
30. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
Cardella CJ; Harding ME; deVeber GA; Honey J; Cook GT
Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
[No Abstract] [Full Text] [Related]
31. Renal transplantation without prednisolone: effects of bone marrow tolerance azathioprine.
Schulak JA; Moritz CE; Hricik DE
Transplant Proc; 1989 Feb; 21(1 Pt 2):1709-11. PubMed ID: 2652560
[No Abstract] [Full Text] [Related]
32. A prospective study on the influence of cyclosporine and azathioprine on renal allograft survival and function.
Henny FC; Kootte AM; van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
Transplant Proc; 1987 Feb; 19(1 Pt 3):1853-5. PubMed ID: 3079050
[No Abstract] [Full Text] [Related]
33. Conversion from standard cyclosporine to low-dose cyclosporine in liver transplant recipients: effect on nephrotoxicity and hypertension beyond one year.
Eid A; Perkins JD; Rakela J; Krom RA
Transplant Proc; 1989 Feb; 21(1 Pt 2):2238-9. PubMed ID: 2652725
[No Abstract] [Full Text] [Related]
34. Triple drug therapy: an alternative regimen in renal transplantation.
Henry ML; Sommer BG; Ferguson RM
Transplant Proc; 1987 Feb; 19(1 Pt 3):1920-1. PubMed ID: 3079059
[No Abstract] [Full Text] [Related]
35. Long-term cyclosporine for renal allograft patients does not cause nephrotoxicity.
Post GR; Moyer TP; Anderson CF; Sterioff S
Transplant Proc; 1987 Feb; 19(1 Pt 2):1761-3. PubMed ID: 3079036
[No Abstract] [Full Text] [Related]
36. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
[No Abstract] [Full Text] [Related]
37. The impact of different immunosuppressant regimens on recurrent glomerulonephritis.
Freedman BI; Graves JW; Burkart JM; Callahan MF; Tell GS; Heise ER; Adams PL
Transplant Proc; 1989 Feb; 21(1 Pt 2):2121-2. PubMed ID: 2652685
[No Abstract] [Full Text] [Related]
38. Conversion from cyclosporine to azathioprine in renal graft recipients.
MacDonald AS; Belitsky P; Gupta R; Bitter-Suermann H; Campbell R; Cohen A; Lannon SG
Transplant Proc; 1985 Aug; 17(4):1940-2. PubMed ID: 3895634
[TBL] [Abstract][Full Text] [Related]
39. Bone repair in cyclosporin treated renal transplant patients.
Wilmink JM; Bras J; Surachno S; van Heyst JL; van der Horst JM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1492-4. PubMed ID: 2652480
[No Abstract] [Full Text] [Related]
40. Phenotypic analysis of interstitial infiltrates in kidney allograft biopsies after one year of cyclosporine therapy.
Versluis DJ; ten Kate FJ; Wenting GJ; Weimar W
Transplant Proc; 1989 Feb; 21(1 Pt 2):1670-1. PubMed ID: 2496494
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
